Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | Bl, ELISA, IF, IHC | 
| Reactivities | Human | 
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | Bl, ELISA, IF, IHC | 
| Reactivities | Human | 
Recombinant Anti-WDR5 (Clone RAB-C223)
| Applications | ChIP, ELISA, FC, IF | 
| Reactivities | Human | 
Recombinant Anti-L3MBTL1 (Clone RAB-C213)
| Applications | ChIP, ELISA, FC, IF | 
| Reactivities | Human | 
Recombinant Anti-SETD7 (Clone RAB-C220)
| Applications | ChIP, ELISA, FC, IF | 
| Reactivities | Human | 
Recombinant Anti-BRD4 (Clone RAB-C131)
| Applications | ChIP, ELISA, FC, IF | 
| Reactivities | Human | 
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | Bl, FC | 
| Reactivities | Human | 
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC | 
| Reactivities | Human | 
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC | 
| Reactivities | Human | 
Recombinant Anti-Phl p 1 (Clone Clone 25)
| Applications | Dot, ELISA, WB | 
| Reactivities | Rat | 
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
| Applications | ELISA, IHC, WB | 
| Reactivities | Human | 
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
| Applications | ELISA, IHC, WB | 
| Reactivities | Human | 
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
| Applications | Bl, FC, IHC | 
| Reactivities | Human | 
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
| Applications | Bl, FC, IP | 
| Reactivities | Human, Monkey | 
Recombinant Anti-TDRD3 (Clone RAB-C419)
| Applications | ChIP, ELISA, IF | 
| Reactivities | Human | 
Recombinant Anti-FOXP4 (Clone RAB-S40)
| Applications | ELISA, FC, IF | 
| Reactivities | Human | 
